In late 2020, the US Food and Drug Administration (FDA) approved plasma kallikrein inhibitor berotralstat, making it the first oral, once-a-day treatment available for the
Read more
Home ยป
In late 2020, the US Food and Drug Administration (FDA) approved plasma kallikrein inhibitor berotralstat, making it the first oral, once-a-day treatment available for the
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SOLONE Prednisolone (Pred-NISS-oh-lone) Consumer Medicine Information What is in this leaflet This
Read more